Article in Circulation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Maged M CostantineDepartment of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus (M.M.C.).ORCID 0000-0001-9616-0006
Kirsten Lawrence-ClearyDepartment of Obstetrics and Gynecology, Yale University, New Haven, CT (K.L.-C.).
Georges SaadeDepartment of Obstetrics and Gynecology, The University of Texas Medical Branch, Galveston (G.S.).
Ronald J WapnerDepartment of Obstetrics and Gynecology, Columbia University, New York, NY (R.J.W.).
Funding
Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD040485 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Noelia Milena Modad Zork · 2016 to 2026
$3.6M
NICHD Maternal Fetal Medicine Units NetworkUG1HD027915 · NICHD · OHIO STATE UNIVERSITY · PI Maged Costantine · 2016 to 2026
$3.3M
NICHD Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD053097 · NICHD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PACHECO, LUIS D · 2016 to 2024
$2.5M
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk womenUH3HL140131 · NHLBI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI COSTANTINE, MAGED · 2019 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Letter by Costantine et al Regarding Article, "Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia". · full record | OpenQuestion